{"pub": "investing.com", "url": "https://za.investing.com/news/stock-market-news/update-1takeda-sells-mideast-africa-drug-portfolio-to-switzerlands-acino-1966061", "downloaded_at": "2019-10-15 09:08:55.066061+00:00", "title": "UPDATE 1-Takeda sells Mideast, Africa drug portfolio to Switzerland's Acino", "language": "en", "text": "\u00a9 Reuters. UPDATE 1-Takeda sells Mideast, Africa drug portfolio to Switzerland's Acino\n\n* Takeda is selling non-core assets after $59 bln Shire purchase\n\n* Deal left Takeda highly indebted\n\n* Sale expected to close in quarter ending March\n\n* Takeda will continue to make the drugs for Acino (Adds further detail of sale)\n\nTOKYO, Oct 15 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Tuesday it will sell a portfolio of over-the-counter (OTC) and prescription medicines in the Middle East and Africa to Swiss pharmaceuticals company Acino for more than $200 million.\n\nThe sale, which Takeda said in a statement is expected to close in the quarter ending March, comes as Japan's biggest drugmaker looks to trim its debt following the $59 billion purchase of Shire. gained global heft through the Shire acquisition but left it highly indebted. It has pledged to shed non-core assets while focusing on five key areas - oncology, gastroenterology, neuroscience, rare disease, and plasma-derived therapies.\n\nTakeda said it will continue to manufacture the drugs for Acino, which is backed by Avista Capital AVAAA.UL and Nordic Capital.", "description": "UPDATE 1-Takeda sells Mideast, Africa drug portfolio to Switzerland's Acino", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEC0Q0MJ_L.jpg", "published_at": "2019-10-15"}